Naoko Takebe to Thrombocytopenia
This is a "connection" page, showing publications Naoko Takebe has written about Thrombocytopenia.
Connection Strength
0.021
-
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):481-5.
Score: 0.021
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.